World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 1 March 2022
Main ID:  ISRCTN11953002
Date of registration: 26/02/2015
Prospective Registration: No
Primary sponsor: Alexandra Health National Medical Research Centre - Centre Grant Pitch For Fund 2014
Public title: Effectiveness of a ‘lung age’ intervention on smoking cessation rate in a Singaporean community
Scientific title: A pilot randomised controlled trial on the effectiveness of a ‘lung age’ intervention on smoking cessation rate in a Singaporean community
Date of first enrolment: 01/11/2014
Target sample size: 108
Recruitment status: Completed
URL:  https://www.isrctn.com/ISRCTN11953002
Study type:  Interventional
Study design:  Pilot randomised controlled trial (Prevention)  
Phase:  Not Specified
Countries of recruitment
Singapore
Contacts
Name: Imran    Muhammad
Address:  Khoo Teck Puat Hospital 90 Yishun Central 768828 Singapore Singapore
Telephone:
Email:
Affiliation: 
Name: Wang    Wenru
Address:  Alice Lee Centre for Nursing Studies NUS, Yong Loo Lin School of Medicine - Clinical Research Centre (MD11), 10 Medical Drive 117597 Singapore Sint Maarten (Dutch part)
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. Currently smoking
2. Aged 35 years old and above
3. Able to read and/or speak in English and/or Mandarin

Exclusion criteria:
1. Have a known history of major psychiatric illness
2. History of Respiratory related diseases: COPD, asthma, bronchioectasis
3. Ejection fraction <40 %, or diagnosed with congestive cardiac failure
4. Diagnosed with acute myocardial infarction within 1 month
5. Diagnosed with fluid overload / acute pulmonary oedema
6. Receiving oxygen therapy
7, Recent eye/thoracic/abdominal surgery
8. Chest/abdominal/oral and facial pain
9. Hyperventilation syndrome


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Smoking cessation
Mental and Behavioural Disorders
Smoking cessation
Intervention(s)
A convenience sample of 108 participants will be recruited from population health screenings conducted by a tertiary public hospital in Singapore with 54 participants in the experimental group and 54 in the control group. Participants in the experimental group will receive a Lung age intervention, consisting of lung age determination and education as well as smoking cessation advice, while the researchers will provide those in the control group with the usual smoking education.
Primary Outcome(s)

1. To explore the feasibility of applying the “lung age” intervention among the smoking community in Singapore.
2. To evaluate the effectiveness of the “lung age’ intervention on smoking cessation rates, smoking abstinence self-efficacy and nicotine dependence and among this group of population. Data will be collected at the baseline and again at the third and sixth month follow-ups. Data will be analysed using IBM SPSS 22.
Secondary Outcome(s)
No secondary outcome measures
Secondary ID(s)
N/A
Source(s) of Monetary Support
Alexandra Health NMRC Centre Grant Pitch For Fund 2014
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Singapore National Health Group Domain Specific Review Board (DSRB) - Domain F NHG DSRB, 04/09/2014, ref: 2014/00711
Results
Results available: Yes
Date Posted:
Date Completed: 03/09/2015
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history